TRAVEL / Special Interest / Disability

Paper · Semantic Scholar

Aims: Treatment-resistant depression (TRD) is common and associated with substantial disability and economic burden. It is estimated to affect over 100 million people worldwide and approximately 2.7 million people in the United Kingdom. Ketamine has emerged as a novel therapy for TRD, with studies demonstrating rapid antidepressant effects. However, ketamine is also used recreationally and can result in multi-system…

Reference · Wikidata

impairments, activity and participation limitations of a person